WELLS FARGO & COMPANY/MN - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$211,434
+1.5%
213,0000.0%0.00%
Q4 2022$208,386
+0.7%
213,0000.0%0.00%
Q3 2022$207,000
+1492.3%
213,000
+1538.5%
0.00%
Q2 2022$13,0000.0%13,0000.0%0.00%
Q1 2022$13,0000.0%13,0000.0%0.00%
Q4 2021$13,0000.0%13,0000.0%0.00%
Q3 2021$13,000
-99.5%
13,000
-99.5%
0.00%
-100.0%
Q2 2021$2,727,000
+156.5%
2,763,000
+166.7%
0.00%
Q1 2021$1,063,000
-23.0%
1,036,000
-31.6%
0.00%
Q4 2020$1,380,000
-35.2%
1,515,000
-35.5%
0.00%
-100.0%
Q3 2020$2,131,000
+396.7%
2,350,000
+370.0%
0.00%
Q2 2020$429,000
+10.0%
500,0000.0%0.00%
Q1 2020$390,000
-7.6%
500,0000.0%0.00%
Q4 2019$422,000
+1.2%
500,0000.0%0.00%
Q3 2019$417,000
-50.8%
500,000
-50.0%
0.00%
Q2 2019$847,0001,000,0000.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders